A multifaceted approach to safety: The synergistic detection of adverse drug events in adult inpatients

Journal of Patient Safety

Volumn 4, Issue 3, 2008, Pages 184-190

  Ferranti, Jeffrey ^a   Horvath, Monica M ^a,d   Cozart, Heidi ^a   Whitehurst, Julie ^a   Eckstrand, Julie ^a   Pietrobon, Ricardo ^b,c   Rajgor, Dimple ^b   Ahmad, Asif ^a  

^a Department of Pediatrics ^*  (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adverse drug event; Patient safety; Surveillance; Voluntary reporting

Indexed keywords

EID: 67650098549     PISSN: 15498417     EISSN: 15498425     Source Type: Journal    
DOI: 10.1097/PTS.0b013e318184a9d5     Document Type: Article

References (28)

1. Institute of medicine. Preventing Medication Errors: Quality Chasm Series. Washington, DC: National Academy Press, 2006.
2. Phillips DP, Bredder CC. Morbidity and mortality from medical errors: An increasingly serious public health problem. Annu Rev Public Health. 2002;23:135-150.
3. Patient safety: achieving a new standard of care. Institute of Medicine Report. Washington, DC: National Academy Press, 2004.
4. Nebeker JR, Hoffman JM, Weir CR, et al. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med. 2005; 165:1111-1116.
5. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA. 1997;277:307-311.
6. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. JAm Med Inform Assoc. 1998;5:305-314.
7. Murff HJ, Patel VL, Hripcsak G, et al. Detecting adverse events for patient safety research: a review of current methodologies. JBiomed Inform. 2003;36:131-143.
8. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual SafHealth Care. 2003;12:194-200.
9. Resar RK, Rozich JD, Classen D. Methodology and rationale for the measurement of harm with trigger tools. Qual SafHealth Care. 2003;12(suppl 2):ii39-ii45.
10. Resar RK, Rozich JD, Simmonds T, et al. A trigger tool to identify adverse events in the intensive care unit. Jt Comm J Qual Patient Saf. 2006; 32:585-590.
11. Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847-2851.
12. Honigman B, Lee J, Rothschild J, et al. Using computerized data to identify adverse drug events in outpatients. JAm Med Inform Assoc. 2001;8:254-266.
13. Kilbridge PM, Alexander L, Ahmad A. Implementation of a system for computerized adverse drug event surveillance and intervention at an academic medical center. J Clin Outcomes Manag. 2006;13:94-100.
14. Kilbridge PM, Campbell UC, Cozart HB, et al. Automated surveillance for adverse drug events at a community hospital and an academic medical center. JAm Med Inform Assoc. 2006;13:372-377.
15. Szekendi MK, Sullivan C, Bobb A, et al. Active surveillance using electronic triggers to detect adverse events in hospitalized patients. Qual Saf Health Care. 2006;15:184-190.
16. Ferranti J, Horvath M, Cozart H, et al. Re-evaluating the safety profile of pediatrics: a comparison ofcomputerized adverse drug event surveillance and voluntary reporting in the pediatric environment. Pediatrics. 2008;121:e1201-1207.
17. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140:795-801.
18. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-245.
19. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-46.
20. Horton JD, Bushwick BM. Warfarin therapy: Evolving strategies in anticoagulation. Am Fam Physician. 1999;59:635-646.
21. Bates DW, Cullen DJ, Laird N, et al. Incidence ofadverse drug events and potential adverse drug events. Implications for prevention. Ade prevention study group. JAMA. 1995;274:29-34.
22. Callum JL, Kaplan HS, Merkley LL, et al. Reporting of near-miss events for transfusion medicine: Improving transfusion safety. Transfusion. 2001;41:1204-1211.
23. Fanikos J, Cina JL, Baroletti S, et al. Adverse drug events in hospitalized cardiac patients. Am J Cardiol. 2007;100:1465-1469.
24. Kane-Gill SL, Devlin JW. Adverse drug event reporting in intensive care units: A survey of current practices. Ann Pharmacother. 2006;40: 1267-1273.
25. Moore TJ, Weiss SR, Kaplan S, et al. Reported adverse drug events in infants and children under 2 years of age. Pediatrics. 2002;110:e53.
26. Pronovost PJ, Thompson DA, Holzmueller CG, et al. Toward learning from patient safety reporting systems. J Crit Care. 2006;21:305-315.
27. Snijders C, van Lingen RA, Molendijk A, et al. Incidents and errors in neonatal intensive care: a review of the literature. Arch Dis Child Fetal Neonatal Ed. 2007;92:F391-398.
28. Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: Development and evaluation in a community teaching hospital. JAMA. 1998;280:1317-1320.